Cochlear Limited (ASX: COH) is a medical device company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr Graeme Clark. Today, the company holds over two-thirds of the worldwide hearing implant market, with more than 250,000 people receiving one of Cochlear’s implants since 1982.
Cochlear was named Australia’s most innovative company in 2002 and 2003, and one of the world’s most innovative companies by Forbes in 2011.
Traded as: ASX: COH
Industry: Biotechnology
Founded: 1981
Headquarters: Sydney, Australia
Products:
- Cochlear implants
- Bone-anchored hearing aids
- Cochlear wireless accessories
- Bone anchored prosthetics
Website: www.cochlear.com